Ellen Herlaar

R406, an Orally Available Spleen Tyrosine Kinase Inhibitor Blocks Fc Receptor Signaling and Reduces Immune Complex-Mediated Inflammation

Sylvia Braselmann, Vanessa Taylor, H. Zhao et al. · Journal of Pharmacology and Experimental Therapeutics · 2006 · 508 citations

Identification of the Syk kinase inhibitor R112 by a human mast cell screen

Alexander B. Rossi, Ellen Herlaar, Sylvia Braselmann et al. · Journal of Allergy and Clinical Immunology · 2006 · 80 citations · Full text

Signal Transduction, Allergy, Signaling Pathway +6

MK: a pluripotential embryonic stem-cell-derived neuroregulatory factor

Victor Nurcombe, N Fraser, Ellen Herlaar et al. · Development · 1992 · 63 citations

Retinoic Acid, Cell Proliferation, Social Sciences +16

Immunotoxicity assessment for the novel Spleen tyrosine kinase inhibitor R406

Yanhong Zhu, Ellen Herlaar, Esteban S. Masuda et al. · Toxicology and Applied Pharmacology · 2007 · 51 citations

Immunotoxicity Assessment, Autoimmune Disease, Immunotoxicology +8

Novel Immunosuppression

T. Deuse, Jeffrey B. Velotta, Grant Hoyt et al. · Transplantation · 2008 · 34 citations